Global Point of Care Glucose Testing Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Lancing Devices, Test Strips, Blood-Glucose Meter), By End-use (Hospital, Clinics, Home Care Settings, Diagnostic Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.

Global Point of Care Glucose Testing Market Insights Forecasts to 2035

• The Global Point of Care Glucose Testing Market Size Was Estimated at USD 3.46 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.02% from 2025 to 2035
• The Worldwide Point of Care Glucose Testing Market Size is Expected to Reach USD 5.34 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

Get more details on this report -

Request Free Sample PDF

The global point of care glucose testing market size was worth around USD 3.46 billion in 2024 and is predicted to grow to around USD 5.34 billion by 2035 with a compound annual growth rate (CAGR) of 4.02% from 2025 to 2035. The growing prevalence of diabetes, the upsurging need for convenient & accurate glucose monitoring, and technological advancements are driving the point of care glucose testing market globally.

 

Market Overview

The point of care glucose testing market is the market emphasizing the production and distribution of devices and systems used for measuring blood glucose levels, providing quick, near-patient results for timely treatment decisions for diabetic patients. Point-of-care tests provide analytical information that can be used to make decisions at the patient’s bedside, as opposed to laboratory tests that must be run at a central laboratory. It is a widely used tool to enable the immediate determination of glucose levels in hospitalized patients and facilitate rapid treatment decisions in response to fluctuations in glycemia. There is an increasing preference for diabetes management among healthcare professionals to limit the mortality rate. PoC glucose testing solutions are increasingly adopted, with the increasing awareness about diabetes management, increased prevalence, poor health access, and scarcity of healthcare professionals. Integration of a continuous glucose monitoring system for the development of advanced sensor technologies is transforming the way of monitoring and management of glucose levels.

The trend towards seamless data sharing, real-time monitoring, and improved disease management due to the integration of glucose testing devices with digital health platforms and emphasis on remote patient monitoring is bolstering the market growth opportunities for point-of-care glucose testing.

 

Report Coverage

This research report categorizes the Point of Care Glucose Testing market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Point of Care Glucose Testing market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Point of Care Glucose Testing market.

 

Driving Factors

The growing prevalence of diabetes is responsible for driving the market demand for point of care glucose testing. It was estimated that approximately 589 million adults aged between 20-79 years are living with diabetes, and over 4 in 5 adults (81%) with diabetes live in low and middle-income countries, according to the International Diabetes Federation. Technological advancements in point-of-care glucose testing, including the miniaturization of devices, improved sensor technology, and integration of wireless connectivity for data transmission to electronic health records, are promoting the market growth.

 

Restraining Factors

An increased price of the devices is limiting their adoption, especially for low-income individuals and healthcare facilities, thereby hampering the market growth. Challenges associated with the accuracy and precision of glucose testing devices are restraining the market. Complex and time-consuming regulatory policies slow down the market growth.

 

Market Segmentation

The point of care glucose testing market share is classified into product type and end-use.

• The test strips segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the point of care glucose testing market is divided into lancing devices, test strips, and blood-glucose meter. Among these, the test strips segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Test strips used for glucose testing typically contain enzymes that react with glucose and produce a color change. Further, they are user-friendly, requiring minimal training, and are often portable, allowing for on-the-spot testing across diverse environments. The increased accuracy and precision offered in glucose measurement for effective diabetes management are propelling the market in the test strips segment.

• The home care settings segment dominated the point of care glucose testing market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-use, the point of care glucose testing market is divided into hospital, clinics, home care settings, and diagnostic centers. Among these, the home care settings segment dominated the point of care glucose testing market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. There is an increased number of diabetes patients who check their diabetes to observe the effect of meals at home. An increasing prevalence of diabetes, with the rising demand for point-of-care testing, especially among older adults, contributes to propelling the market in the home care settings segment.

Regional Segment Analysis of the Point of Care Glucose Testing Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the point of care glucose testing market over the predicted timeframe.

Get more details on this report -

Request Free Sample PDF

North America is anticipated to hold the largest share of the point of care glucose testing market over the predicted timeframe. An increasing availability of glucose testing products, along with an increasing government expenditure on healthcare for diabetes management, is contributing to driving the market. Further, the adoption of portable glucose testing devices in the healthcare sector, along with an emphasis on preventive care, is propelling the market growth.

 

Asia Pacific is expected to grow at a rapid CAGR in the point of care glucose testing market during the forecast period. The growing awareness about early disease detection, as well as an upsurging demand for rapid and accurate diagnostic results, is driving the point of care glucose testing market. Further, the quick medical facility expansion, along with an expanding application of point of care glucose testing for personal and professional purposes, is propelling the market growth.

 

Europe is anticipated to grow at a substantial rate in the point of care glucose testing market during the predicted timeframe. An upsurging awareness about the PoC glucose testing by the government institutions and organizations is contributing to driving the market demand for point of care glucose testing. Further, a remote monitoring solution for efficient healthcare management is promoting the market growth.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the point of care glucose testing market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• F. Hoffmann-La Roche Ltd.
• Abbott
• Nipro
• PlatInium Equity Advisors, LLC (Lifescan, Inc.)
• Nova Biomedical
• ACON Laboratories
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• Bayer AG/Ascensia Diabetes Care Holdings AG
• EKF Diagnostics
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

 

Recent Development

 

• In January 2022, Roche announced the launch of the cobas pulse system in select countries accepting the CE Mark. The cobas pulse system marks Roche Diagnostics' newest generation of connected point-of-care solutions for professional blood glucose management.

 

• In August 2021, LifeScan, a world leader in blood glucose monitoring, serving more than 20 million people with diabetes and the maker of the iconic OneTouch brand products, and Cecelia Health, one of the nation’s most scalable virtual care companies focused on diabetes and chronic disease management, announced the addition of a fully integrated live telehealth service with the OneTouch Reveal app.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the point of care glucose testing market based on the below-mentioned segments:  

 

Global Point of Care Glucose Testing Market, By Product Type  

• Lancing Devices
• Test Strips
• Blood-Glucose Meter

 

Global Point of Care Glucose Testing Market, By End-use

• Hospital
• Clinics
• Home Care Settings
• Diagnostic Centers

 

Global Point of Care Glucose Testing Market,

 

By Regional Analysis

North America

• US
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia Pacific

South America

• Brazil
• Argentina
• Rest of South America

Middle East & Africa

• UAE
• Saudi Arabia
• Qatar
• South Africa
• Rest of the Middle East & Africa